UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis-Reference-Cited by-同舟云学术

UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis

Published:2022-09-05 Issue:17 Volume:14 Page:7003-7013
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zhou Yingchun¹²,Zhang Junbin¹²,Gong Jinglin¹²,Tang Xi¹²,Zhang Chengyao¹²

Affiliation:

1. Department of Head and Neck Cancer Center, Chongqing University Cancer Hospital, Chongqing 400030, China

2. Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference18 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.;Bray;CA Cancer J Clin,2021

2. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.;Baris Karakullukcu;Nat Commun,2021

3. Cancer Statistics, 2021.;Jemal;CA Cancer J Clin,2021

4. Radioimmunotherapy for the treatment of head and neck cancer.;Raben;Lancet Oncol,2019

5. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.;Dong;Int J Biochem Cell Biol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UBE2C regulates the KEAP1/NRF2 signaling pathway to promote the growth of gastric cancer by inhibiting autophagy;International Journal of Biological Macromolecules;2024-09

2. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation;BMC Cancer;2024-04-18

3. Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study;Scientific Reports;2024-03-15

4. System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma;PLOS ONE;2023-08-03